Acupoint injection ameliorates Th1/Th2 imbalance through Toll-like receptor 4/activator protein-1 signal pathway and improves inflammatory response in rats with allergic rhinitis
|更新时间:2023-08-11
|
Acupoint injection ameliorates Th1/Th2 imbalance through Toll-like receptor 4/activator protein-1 signal pathway and improves inflammatory response in rats with allergic rhinitis
ZHOU Yu-ling, ZHANG Qian, WANG Yu-jia, et al. Acupoint injection ameliorates Th1/Th2 imbalance through Toll-like receptor 4/activator protein-1 signal pathway and improves inflammatory response in rats with allergic rhinitis[J]. Acupuncture research, 2023, 48(4): 366-371.
DOI:
ZHOU Yu-ling, ZHANG Qian, WANG Yu-jia, et al. Acupoint injection ameliorates Th1/Th2 imbalance through Toll-like receptor 4/activator protein-1 signal pathway and improves inflammatory response in rats with allergic rhinitis[J]. Acupuncture research, 2023, 48(4): 366-371. DOI: 10.13702/j.1000-0607.20220837.
Acupoint injection ameliorates Th1/Th2 imbalance through Toll-like receptor 4/activator protein-1 signal pathway and improves inflammatory response in rats with allergic rhinitis
Objective To observe the effect of acupoint injection on serum T helper(Th)1/Th2 related cytokines
and the expression levels of Toll-like receptor 4(TLR4)
myeloid differentiation factor 88(MyD88) and activator protein-1(AP-1) of nasal mucosa in allergic rhinitis(AR) rats
so as to explore its mechanism underlying improvement of AR. Methods Thirty-two SD rats were randomly divided into normal
model
non-acupoint injection and acupoint injection groups(n=8 in each group). The AR model was established by ovalbumin sensitization. In the acupoint injection group
“Yintang”(GV24
+
) and bilateral “Yingxiang”(LI20) were selected for injection of mixture solution of dexamethasone and lidocaine(0.05 mL/acupoint)
once every 4 days for a total of 4 times. The non-acupoints
located at the midpoint between the “Houhai” and “Huantiao”(GB30) on the bilateral hips and the sites 5 cm inferior to the axillary were injected with the same dose of mixture solution as that in the acupoint injection group. The AR severity was assessed by cumulative quantification scoring methods(including the numbers of nose-catching and sneezes
and the amount of nasal secretions in 30 min). The pathological changes of nasal mucosa were observed by HE staining. The contents of immunoglobulin E(IgE)
interleukin(IL)-4 and interferon(IFN)-γ in serum were detected by ELISA. The expressions of TLR4 and MyD88 in nasal mucosa was detected by immunofluorescence. The expression of AP-1 in nasal mucosa was detected by Western blot. Results Following modeling
the AR symptom score
serum IgE and IL-4 contents and expression of TLR4
MyD88 and AP-1 of nasal mucosa were significantly increased in the model group than those in the normal group(P
<
0.01)
while the serum IFN-γ content was significantly decreased(P
<
0.01). Compared with the model group and non-acupoint injection group
the AR symptom score
the serum contents of IgE and IL-4 and the expressions of TLR4
MyD88 and AP-1 in nasal mucosa were significantly decreased in the acupoint injection group(P
<
0.01
P
<
0.05)
while the serum IFN-γ content was significantly increased(P
<
0.01). H.E. staining of the nasal mucosa showed that most of the epithelium fell off
the lamina propria vessels expanded
the glands proliferated
and eosinophils and lymphocytes infiltrated in the model and non-acupoint injection groups
and those were significantly improved in the acupoint injection group. Conclusion Acupoint injection can effectively improve allergic inflammation of the nose in AR rats
which may be related with its function in inhibiting the abnormal activation of TLR4/AP-1 signaling pathway and regulating the imbalance of Th1/Th2.
Acupoint injection inhibiting abnormal secretion of mucin and inflammatory reaction of nasal mucosa in rats with allergic rhinitis through the p38 mitogen-activated protein kinase pathway
Synergistic effect of acupoint injection and moxibustion or catgut embedding or acupuncture on symptoms and expression of Th1/Th2 related cytokines in nasal mucosa of rats with allergic rhinitis
Acupoint injection improves allergic rhinitis by balancing Th17/Treg in allergic rhinitis rats
Acupoint Injection at “Yingxiang”(LI 20)and “Yintang”(GV 29)May Relieve Nasal Allergic Symptoms Possibly by Down-regulating Expression of Histamine Receptor H 1 and H 4 in Nasal Mucosa of Allergic Rhinitis Rats
Related Author
LI Li-hong
ZHANG Qian
WANG Yu
ZHOU Yu-ling
HOU Xun-rui
WANG Yu-jia
LI Li-hong
WANG Yu
Related Institution
Clinical Medical College, Guizhou Medical University
Clinical Medical College of Guizhou Medical University
the Affliated Hospital,Guizhou Medical University
The Affliated Hospital of Guizhou Medical University
Zunyi Municipal Hospital of Traditional Chinese Medicine